"In silico study identifies RO 28-2653 as a novel drug against SARS-CoV2 ..."

Srija Mukherjee, Santanu Paul (2021)

> Home

Details and statistics

DOI: 10.1504/IJCBDD.2021.121622

access: closed

type: Journal Article

metadata version: 2024-10-06

- view
  - electronic edition via DOI
  - unpaywalled version
  authority control:
- export record
  dblp key:
  - journals/ijcbdd/MukherjeeP21
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/ijcbdd/MukherjeeP21
Srija Mukherjee, Santanu Paul:
In silico study identifies RO 28-2653 as a novel drug against SARS-CoV2 mutant strains. Int. J. Comput. Biol. Drug Des. 14(6): 457-480 (2021)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.